Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients
Clement Lo, Min Jun, Sunil V. Badve, et al.
Cochrane library (2017)
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Peter Rossing, Maria Luiza Caramori, Juliana C.N. Chan, et al.
Kidney International (2022) Vol. 102, Iss. 5, pp. S1-S127
Open Access | Times Cited: 702
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
Lawrence Blonde, Guillermo E. Umpierrez, Sarah Reddy, et al.
Endocrine Practice (2022) Vol. 28, Iss. 10, pp. 923-1049
Open Access | Times Cited: 315
Post-transplant diabetes mellitus in patients with solid organ transplants
Trond Jenssen, Anders Hartmann
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 3, pp. 172-188
Closed Access | Times Cited: 215
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Clement Lo, Tadashi Toyama, Ying Wang, et al.
Cochrane library (2018)
Open Access | Times Cited: 89
Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention
Caterina Conte, Antonio Secchi
Acta Diabetologica (2018) Vol. 55, Iss. 8, pp. 763-779
Closed Access | Times Cited: 65
Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota
Wenjiao Jiao, Zijian Zhang, Yue Xu, et al.
American Journal of Transplantation (2020) Vol. 20, Iss. 9, pp. 2413-2424
Open Access | Times Cited: 50
Glycyrrhizic Acid Prevents Diabetic Nephropathy by Activating AMPK/SIRT1/PGC-1α Signaling in db/db Mice
Shaozhang Hou, Ting Zhang, Yuan Li, et al.
Journal of Diabetes Research (2017) Vol. 2017, pp. 1-10
Open Access | Times Cited: 51
Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase
Anusha Seneviratne, Luke Cave, Gareth Hyde, et al.
Cardiovascular Research (2020) Vol. 117, Iss. 5, pp. 1295-1308
Open Access | Times Cited: 41
Efficacy and Safety of SGLT-2 Inhibitors for Treatment of Diabetes Mellitus among Kidney Transplant Patients: A Systematic Review and Meta-Analysis
Api Chewcharat, Narut Prasitlumkum, Charat Thongprayoon, et al.
Medical Sciences (2020) Vol. 8, Iss. 4, pp. 47-47
Open Access | Times Cited: 34
Metabolic risk profile in kidney transplant candidates and recipients
Giovanni Piotti, Ilaria Gandolfini, Alessandra Palmisano, et al.
Nephrology Dialysis Transplantation (2018) Vol. 34, Iss. 3, pp. 388-400
Closed Access | Times Cited: 31
Management of diabetes mellitus in patients undergoing liver transplantation
Valeria Grancini, Veronica Resi, Eva Palmieri, et al.
Pharmacological Research (2019) Vol. 141, pp. 556-573
Closed Access | Times Cited: 26
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients
Clement Lo, Tadashi Toyama, Megumi Oshima, et al.
Cochrane library (2020) Vol. 2020, Iss. 8
Open Access | Times Cited: 22
Anaesthetic Approach to Enhanced Recovery after Surgery for Kidney Transplantation: A Narrative Review
Slawomir Jaszczuk, Shweta Natarajan, Vassilios Papalois
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3435-3435
Open Access | Times Cited: 11
Topical Glucocorticoid Use and the Risk of Posttransplant Diabetes
Simon Bøtker, Henrik Birn, Lara Aygen Øzbay
Case Reports in Endocrinology (2023) Vol. 2023, pp. 1-5
Open Access | Times Cited: 4
Effect of metformin use on graft and patient survival in kidney transplant recipients with type 2 diabetes: a systematic review protocol
Farooq Shamshad, Somkanya Tungsanga, Peter Senior, et al.
BMJ Open (2024) Vol. 14, Iss. 5, pp. e078393-e078393
Open Access | Times Cited: 1
New-Onset Diabetes Mellitus in Post-renal Transplant Patients on Tacrolimus and Mycophenolate: A Systematic Review
Savitri Aninditha Nandula, Chinmayi Sree Boddepalli, Sai Dheeraj Gutlapalli, et al.
Cureus (2022)
Open Access | Times Cited: 6
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Alaaeldin Bashier, Dileep Kumar, Fakhriya Alalawi, et al.
Dubai Diabetes and Endocrinology Journal (2022) Vol. 28, Iss. 3, pp. 79-92
Open Access | Times Cited: 5
Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure
Jessica Phillips, Jenny H. C. Chen, Esther Ooi, et al.
Frontiers in Clinical Diabetes and Healthcare (2021) Vol. 2
Open Access | Times Cited: 7
Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID)
Caterina Conte, Umberto Maggiore, Gianni Cappelli, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 9, pp. 1427-1441
Open Access | Times Cited: 6
Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation: A review of literatures
Marlene Schwarzenbach, Flavia Elena Bernhard, Cecilia Czerlau, et al.
World Journal of Transplantation (2021) Vol. 11, Iss. 7, pp. 254-262
Open Access | Times Cited: 6
Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review
Nancy Daniela Valencia-Morales, Beatriz Rodríguez-Cubillo, Rómulo Katsu Loayza-López, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1265-1265
Open Access | Times Cited: 2
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies—a joint review from endocrinologists and cardiologists
Lisa M. Raven, Christopher A. Muir, Peter S. Macdonald, et al.
Acta Diabetologica (2022) Vol. 60, Iss. 4, pp. 471-480
Closed Access | Times Cited: 4
Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study
Sandra Aleksić, Ruth Eisenberg, Effie Tsomos, et al.
Diabetes Research and Clinical Practice (2020) Vol. 165, pp. 108221-108221
Open Access | Times Cited: 5
Long-term efficacy and safety of anti-hyperglycaemic agents in new-onset diabetes after transplant: Results from outpatient-based 1-year follow-up and a brief review of treatment options
Debmalya Sanyal, Mansij Biswas, Nayan Chaudhari
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 15, Iss. 1, pp. 13-19
Closed Access | Times Cited: 4
Les inhibiteurs du SGLT2 : une nouvelle ère pour nos patients
Jean‐Michel Halimi
Néphrologie & Thérapeutique (2021) Vol. 17, Iss. 3, pp. 143-148
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top